All Fields
Computer Science
Medicine
FAQ
Contact
Sign in
AC 3933
Known as:
AC-3933
, AC3933
Â
Â
National Institutes of Health
Topic mentions per year
Topic mentions per year
2004-2016
0
1
2
3
2004
2016
Related topics
Related topics
1 relation
Broader (1)
radequinil
Related mentions per year
Related mentions per year
2004-2016
2000
2005
2010
2015
2020
AC 3933
radequinil
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
AC-3933, a benzodiazepine partial inverse agonist, improves memory performance in MK-801-induced amnesia mouse model.
Takashi Hashimoto
,
Yoshihiro Iwamura
Pharmacology, biochemistry, and behavior
2016
AC-3933, a novel benzodiazepine receptor partial inverse agonist, is a drug candidate for cognitive disorders including Alzheimer…Â
(More)
Is this relevant?
2014
2014
In vivo pharmacological characterization of AC-3933, a benzodiazepine receptor partial inverse agonist for the treatment of Alzheimer's disease.
Y. Hatayama
,
T. Hashimoto
,
+4 authors
Nobuyuki Yoshida
Neuroscience
2014
GABAergic neurons are known to inhibit neural transduction and therefore negatively affect excitatory neural circuits in the…Â
(More)
Is this relevant?
2014
2014
Procognitive effect of AC-3933 in aged mice, and synergistic effect of combination with donepezil in scopolamine-treated mice.
Takashi Hashimoto
,
Yuki Hatayama
,
Keiko Nakamichi
,
Naoyuki Yoshida
European journal of pharmacology
2014
We have previously reported that AC-3933, a newly developed benzodiazepine receptor partial inverse agonist, facilitates…Â
(More)
Is this relevant?
2014
2014
Pharmacological properties of AC-3933, a novel benzodiazepine receptor partial inverse agonist.
T. Hashimoto
,
Tsukasa Kiyoshi
,
Hitoshi Kohayakawa
,
Yuki Iwamura
,
Nobuyuki Yoshida
Neuroscience
2014
We investigated in this study the pharmacological properties of AC-3933 (5-(3-methoxyphenyl)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-1…Â
(More)
Is this relevant?
2004
2004
Polymorphic expression of CYP1A2 leading to interindividual variability in metabolism of a novel benzodiazepine receptor partial inverse agonist in dogs.
Masashi Mise
,
Seiji Yadera
,
+4 authors
Toshihiko Fujii
Drug metabolism and disposition: the biological…
2004
5-(3-methoxyphenyl)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-2-oxo-1,2-dihydro-1,6-naphthyridine (AC-3933) is a novel cognitive enhancer…Â
(More)
Is this relevant?
2004
2004
Identification of non-functional allelic variant of CYP1A2 in dogs.
Masashi Mise
,
Takanori Hashizume
,
Satoshi Matsumoto
,
Yoshiaki Terauchi
,
Toshihiko Fujii
Pharmacogenetics
2004
OBJECTIVES Recently, we reported that AC-3933, a novel cognitive enhancer, is polymorphically hydroxylated in beagle dogs and…Â
(More)
Is this relevant?